Most information about the immunogenicity of therapeutic peptides is locked in unstructured clinical reports. The client wanted to extract and structure this data to inform development of safe and effective treatments.
Our Approach
We built a robust extraction pipeline, leveraged large language models for information extraction and evaluated tools for scaling.
The Outcome
Why It Matters
AI-powered NLP can unlock valuable information hidden in clinical reports. This approach accelerates therapeutic development by delivering critical data without manual extraction.
Let’s discuss how we can turn your data into real scientific impact.
Contact us >
For over a century, the life sciences industry has relied on animal models as the standard for predicting drug safety and effect. But today, the industry faces a harsh reality: over 90% of new drugs that appear safe and effective in animal tests ultimately fail in human clinical trials (see for example Ineichen et al. 2024 [1] and Marshall et al. 2023[2])
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.